Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New antiinflammatory agents disclosed by DuPont Merck

Dec. 10, 1996

Another British Biotech compound reaches clinical stage

Dec. 9, 1996

FDA tentatively approves generic NSAID

Dec. 6, 1996

SKB, IDEC initiate phase III testing of antirheumatic antibody

Dec. 6, 1996

Connective Therapeutics acquires rheumatoid arthritis Rx from SKB

Dec. 6, 1996

Phase II trials begin on low-dose interferon alfa for Sjogren's syndrome

Dec. 5, 1996

COX-2 inhibitors under investigation at Glaxo Wellcome

Dec. 3, 1996

Reversible cysteine protease inhibitors reported by Arris

Nov. 28, 1996

Taiho antirheumatic agent possesses novel mechanism of action

Nov. 27, 1996

Rx for Sjogren's syndrome symptoms nearing launch

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...